Home » NIH: Pharmacokinetic-Profile Extending Technology Now Available
NIH: Pharmacokinetic-Profile Extending Technology Now Available
The National Institutes of Health has announced the commercial availability of a platform technology that extends the pharmacokinetic properties of certain classes of drugs.
According to a notice, the licensing offer benefits early-stage drugs and features other advantages such as eliminating renal clearance.
It has applicability to cancer drugs, diabetes drugs and central nervous system drugs.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May